These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26348019)

  • 1. Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.
    Gregson CL; Wheeler L; Hardcastle SA; Appleton LH; Addison KA; Brugmans M; Clark GR; Ward KA; Paggiosi M; Stone M; Thomas J; Agarwal R; Poole KE; McCloskey E; Fraser WD; Williams E; Bullock AN; Davey Smith G; Brown MA; Tobias JH; Duncan EL
    J Bone Miner Res; 2016 Mar; 31(3):640-9. PubMed ID: 26348019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.
    Niziolek PJ; MacDonald BT; Kedlaya R; Zhang M; Bellido T; He X; Warman ML; Robling AG
    J Bone Miner Res; 2015 Oct; 30(10):1822-30. PubMed ID: 25808845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes.
    Niziolek PJ; Farmer TL; Cui Y; Turner CH; Warman ML; Robling AG
    Bone; 2011 Nov; 49(5):1010-9. PubMed ID: 21855668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
    Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
    Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.
    Gregson CL; Poole KE; McCloskey EV; Duncan EL; Rittweger J; Fraser WD; Smith GD; Tobias JH
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2897-907. PubMed ID: 24606091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
    Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
    J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.
    Rickels MR; Zhang X; Mumm S; Whyte MP
    J Bone Miner Res; 2005 May; 20(5):878-85. PubMed ID: 15824861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study.
    Gregson CL; Sayers A; Lazar V; Steel S; Dennison EM; Cooper C; Smith GD; Rittweger J; Tobias JH
    Bone; 2013 Jan; 52(1):380-8. PubMed ID: 23103330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of high bone mass cases from the BARCOS cohort of Spanish postmenopausal women.
    Sarrión P; Mellibovsky L; Urreizti R; Civit S; Cols N; García-Giralt N; Yoskovitz G; Aranguren A; Malouf J; Di Gregorio S; Río LD; Güerri R; Nogués X; Díez-Pérez A; Grinberg D; Balcells S
    PLoS One; 2014; 9(4):e94607. PubMed ID: 24736728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass.
    Gregson CL; Steel SA; O'Rourke KP; Allan K; Ayuk J; Bhalla A; Clunie G; Crabtree N; Fogelman I; Goodby A; Langman CM; Linton S; Marriott E; McCloskey E; Moss KE; Palferman T; Panthakalam S; Poole KE; Stone MD; Turton J; Wallis D; Warburton S; Wass J; Duncan EL; Brown MA; Davey-Smith G; Tobias JH
    Osteoporos Int; 2012 Feb; 23(2):643-54. PubMed ID: 21455762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genetic Architecture of High Bone Mass.
    Gregson CL; Duncan EL
    Front Endocrinol (Lausanne); 2020; 11():595653. PubMed ID: 33193107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.
    Wang X; Zhang H; Hu L; He J; Jiang Q; Ren L; Yu K; Fu M; Li Z; He Z; Zhu J; Wang Y; Jiang Z; Yang G
    Bone; 2024 Oct; 187():117172. PubMed ID: 38909879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low-Density Lipoprotein Receptor-Related Protein 6.
    Whyte MP; Mumm S; Baker JC; Zhang F; Sedighi H; Duan S; Cundy T
    JBMR Plus; 2023 Apr; 7(4):e10717. PubMed ID: 37065631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis.
    Gregson CL; Bergen DJM; Leo P; Sessions RB; Wheeler L; Hartley A; Youlten S; Croucher PI; McInerney-Leo AM; Fraser W; Tang JC; Anderson L; Marshall M; Sergot L; Paternoster L; Davey Smith G; ; Brown MA; Hammond C; Kemp JP; Tobias JH; Duncan EL
    J Bone Miner Res; 2020 Jan; 35(1):92-105. PubMed ID: 31525280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.
    Yorgan TA; Peters S; Jeschke A; Benisch P; Jakob F; Amling M; Schinke T
    J Bone Miner Res; 2015 Jul; 30(7):1175-83. PubMed ID: 25640331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association study of extreme high bone mass: Contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes.
    Gregson CL; Newell F; Leo PJ; Clark GR; Paternoster L; Marshall M; Forgetta V; Morris JA; Ge B; Bao X; Duncan Bassett JH; Williams GR; Youlten SE; Croucher PI; Davey Smith G; Evans DM; Kemp JP; Brown MA; Tobias JH; Duncan EL
    Bone; 2018 Sep; 114():62-71. PubMed ID: 29883787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the Bone Phenotype and microRNA Profile in Adults With Low-Density Lipoprotein Receptor-Related Protein 5-High Bone Mass (LRP5-HBM) Disease.
    Lauterlein JL; Gossiel F; Weigl M; Eastell R; Hackl M; Hermann P; Bollerslev J; Frost M
    JBMR Plus; 2021 Sep; 5(9):e10534. PubMed ID: 34532618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutation in LRP5 gene cause rare osteosclerosis: cases studies and literature review.
    Zhao D; Sun L; Zheng W; Hu J; Zhou B; Wang O; Jiang Y; Xia W; Xing X; Li M
    Mol Genet Genomics; 2023 May; 298(3):683-692. PubMed ID: 36971833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.